Computer-aided detection (CAD) developer Medicsight of London announced that its application to list its common shares on the American Stock Exchange (AMEX) has been approved.
The firm said it anticipates that trading on AMEX will begin on December 19 under the symbol MGT, pending continued compliance with all listing requirements on that date.
By AuntMinnie.com staff writers
December 13, 2005
Related Reading
Boyse tapped as Medicsight COO, November 17, 2005
Road to RSNA, Medicsight, November 17, 2005
Medicsight to begin China trial, November 1, 2005
Medicsight, Viatronix partner, October 12, 2005
TeraRecon, Medicsight ally, August 19, 2005
Copyright © 2005 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
